Home
Browse
Search
Latest additions
Policies
FAQ
About Open Access
Browse by Author
Browse by Year
Browsing publications by
Sarah Nicholson
Newcastle Authors
Title
Year
Professor Steven Clifford
Dr Stephen Crosier
Sarah Nicholson
Dr Nicholas Bown
A national feasibility study of real-time central pathology review (CPR) and molecular diagnostics for medulloblastoma
2013
Sarah Nicholson
Dr Nicholas Bown
Professor Steven Clifford
A feasibility study of real-time central pathology review (CPR) and molecular diagnostics for medulloblastoma in the United Kingdom
2011
Professor David Ellison
Sarah Nicholson
Professor Simon Bailey
Professor Steven Clifford
Dr Richard Gilbertson
et al.
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
2011
Professor David Ellison
Dr Hisham Megahed
Dr Sarra Ryan
Dr Meryl Lusher
Sarah Nicholson
et al.
Clinical, pathological, and molecular variables define risk-stratification groups in childhood medulloblastoma
2010
Dr Hisham Megahed
Dr Sarra Ryan
Dr Meryl Lusher
Sarah Nicholson
Professor Simon Bailey
et al.
Clinical, Pathological, and Molecular Variables Define Risk-Stratification Groups in Childhood Medulloblastoma
2010
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Meryl Lusher
Kieran O'Toole
Sarah Nicholson
et al.
DNA methylomics identifies clinically significant epigenetic subgroups of medulloblastoma
2010
Sarah Nicholson
Dr Nicholas Bown
Professor Steven Clifford
Establishment of real-time centralised pathology review (CPR) and molecular diagnostics for medulloblastoma in the United Kingdom
2010
Dr James Hayden
Dr Matthew Allen
Dr Sarra Ryan
Sarah Nicholson
Dr Ed Schwalbe
et al.
Molecular Mechanisms in Supratentorial CNS-PNET development
2010
Professor Steven Clifford
Dr Sarra Ryan
Mike Cole
Dr Meryl Lusher
Kieran O'Toole
et al.
MYC gene family amplification and expression in childhood medulloblastoma: Biological significance and utility for high-risk disease stratification
2010
Sarah Nicholson
Central pathology review of pediatric CNS tumors in the United Kingdom - On behalf of the Children's Cancer and Leukaemia Group
2008